*ASTRA NEW STUDY WILL BE FASTER, NEED LOWER NUMBER OF PATIENTS
*ASTRA DOESN’T EXPECT NEW TRIAL TO HOLD UP UK, EUROPE APPROVALS
*ASTRA CEO SAYS VACCINE CLEARANCE FROM FDA MAY TAKE LONGER
*ASTRA NEW STUDY WILL BE FASTER, NEED LOWER NUMBER OF PATIENTS
*ASTRA DOESN’T EXPECT NEW TRIAL TO HOLD UP UK, EUROPE APPROVALS
*ASTRA CEO SAYS VACCINE CLEARANCE FROM FDA MAY TAKE LONGER